Syndecan-binding protein (SDCBP) was reported to stimulate the advancement of esophageal squamous cell carcinoma (ESCC) and could potentially be a target for ESCC treatment. The gene discussed is SDCBP; the disease is esophageal squamous cell carcinoma.